Novinky

Európska lieková agentúra EMA podporuje biologicky podobné lieky

 

The European Medicines Agency (EMA) and the European Commission have published additional information material on biosimilar medicines, as part of their ongoing collaboration to improve understanding of biosimilars across the European Union (EU).